Intuitive Surgical (ISRG)
has garnered ample attention for its daVinci surgical robots - both
from investors who lust for Intuitive's revenue and earnings growth, and
clinicians looking to either use or question the use of these surgical
robots. A recent paper once again highlighted the obvious -
robot-assisted surgeries cost more - but a closer look at the details of
what the paper did, and did not, say suggests minimal incremental risk
to Intuitive Surgical.
Please read more here:
A New Paper At JAMA Unlikely To Jam Up Intuitive Surgical
Stephen,
ReplyDeleteGood read on this study. It got some discussion of TMF boards, but your take was more thorough than others I read. In studies like this, I also like to see some look at a follow up period. Days in hospital were looked at, but not # of follow on office visits or related rehospitalizations in the next 6 months. There may not have been much difference here (?) but the costs can be significant and often under appreciated.